Abstract Long interspersed element-1 (LINE-1 or L1) retrotransposons represent the only functional family of autonomous transposable elements in humans and formed 17% of our genome. Even though most of the human L1 sequences are inactive, a limited number of copies per individual retain the ability to mobilize by a process termed retrotransposition. The ongoing L1 retrotransposition may result in insertional mutagenesis that could lead to negative consequences such as genetic disease and cancer. For this reason, cells have evolved several mechanisms of defense to restrict L1 activity. Among them, a critical role for cellular deaminases [activation-induced deaminase (AID)/apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) and adenosine deaminases that act on RNA (ADAR) enzymes] has emerged. The majority of the AID/ APOBEC family of proteins are responsible for the deamination of cytosine to uracil (C-to-U editing) within DNA and RNA targets. The ADARs convert adenosine bases to inosines (A-to-I editing) within doublestranded RNA (dsRNA) targets. This review will discuss the current understanding of the regulation of LINE-1 retrotransposition mediated by these enzymes.
Transposable elements in the human genome
Transposable elements (TEs) are genetic elements able to move and amplify within the genome. Long considered as Bjunk DNA^, TEs have had a great impact on the structure, function and evolution of the human genome and represent a large fraction (46%) of it (Orgel et al. 1980; Doolittle and Sapienza 1980; Chenais et al. 2012; Scarfò et al. 2016) . There are two different classes of TEs: DNA transposons that can move via a DNA intermediate by a Bcut and paste^mechanism (reviewed in Feschotte and Pritham 2007) and retrotransposons, the most abundant class of TEs in most mammalian genomes, that mobilize via an RNA intermediate by a Bcopy-and-paste^mechanism (retrotransposition; reviewed in Richardson et al. 2015) . While human DNA transposons are no longer transposition-competent due to inactivating mutations (Lander et al. 2001; Pace 2nd and Feschotte 2007) , long interspersed element-1 (LINE-1 or L1) retrotransposons are the only autonomously active family of TEs in humans and form 17% of our genome (Richardson et al. 2015) . LINE-1s and the non-autonomous short interspersed element-1 (SINEs, such as human Alu elements) are members of the non-long terminal repeat (LTR) class of retrotransposons (Richardson et al. 2015) , while human endogenous retroviruses (ERVs) belong to the LTR class (Stocking and Kozak 2008; Stoye 2012; Mager and Stoye 2015) . The majority of LINE-1 elements in the human genome are inactive fossils due to 5' truncation, internal rearrangements, and point mutations (Lander et al. 2001; Khan et al. 2006) . It has been estimated that only a limited number of L1s (80-100 copies) have retained the ability to mobilize (L1H elements of the PA1 subfamily; Brouha et al. 2003; Sassaman et al. 1997) .
A typical retrotransposition-competent human L1 element is 6 kb in length and contains a 5′ untranslated region (UTR) that functions as an internal promoter, a 3' UTR with a poly (A) signal, and two open reading frames (ORF1 and ORF2) on the sense strand (reviewed in Richardson et al. 2015) . Antisense transcription from the 5' UTR promoter sequence is also well-documented, leading either to the expression of an ORF0 or to the transcription of chimeric transcripts containing sequences of neighboring genes (Speek 2001; Denli et al. 2015; Criscione et al. 2016) . Both ORF1p and ORF2p proteins are required for L1 retrotransposition (Richardson et al. 2015) .
ORF1 encodes for a 40-kDa RNA-binding protein (ORF1p) with nucleic acid chaperone activity in vitro (Holmes et al. 1992; Hohjoh and Singer 1996; Martin and Bushman 2001; Khazina et al. 2011; Martin 2010 ). ORF1p contains a coiled-coiled (CC) domain, a noncanonical RNA recognition motif (RRM) domain and a basic C-terminal domain (CTD; Khazina and Weichenrieder 2009 ). ORF2 encodes a 150-kDa protein with endonuclease (EN) and reverse transcriptase (RT) activities (Feng et al. 1996; Mathias et al. 1991) . The Cterminus of the protein contains a cystein-rich domain of unknown function but with RNA binding capacity (Piskareva et al. 2013) .
L1 replication begins with transcription from the 5' UTR of a bicistronic L1 mRNA that is translated in the cytoplasm, giving rise to the ORF1p and ORF2p proteins that bind their encoding L1 mRNA (cis preference) to form ribonucleoprotein (RNP) complexes (reviewed in Beck et al. 2011) . The L1 RNPs then migrate to the nucleus, where new copies of L1 are synthesized and inserted within the genome through a process named target-primed reverse transcription (TPRT; Luan et al. 1993; Cost et al. 2002) .
The endonuclease activity of ORF2p cleaves the first strand at the genomic consensus target sequence 5′-TTTT/A-3′ (Feng et al. 1996) , and, subsequently, the RT activity of ORF2p uses the exposed 3′-OH group to initiate first-strand LINE-1 cDNA synthesis using the bound RNA as a template (Cost et al. 2002) . The final steps of the TPRT process lead to the insertion of a de novo LINE-1 copy at a new genomic location.
Moreover, the L1 machinery can also function in trans to mobilize non-autonomous retrotransposons such as SINE-VNTR-Alu (SVA) and Alu elements (Ostertag et al. 2003; Raiz et al. 2012; Dewannieux et al. 2003) and cellular mRNAs leading to the formation of processed pseudogenes (Esnault et al. 2000) .
LINE-1 retrotransposition events can occur in embryonic stem cells (ESCs; Garcia-Perez et al. 2007) , early embryos (van den Hurk et al. 2007 ), pluripotent stem cells (iPSCs; Wissing et al. 2012; Klawitter et al. 2016 ) and germline (Richardson et al. 2017) . In regards to retrotransposition in adult somatic tissues, there are not many data (Doucet-O'Hare et al. 2015 Goodier 2016) , except for a certain region of the brain (e.g. hippocampus; Muotri et al. 2005; Coufal et al. 2009 ). Of note, engineered L1s were shown to retrotranspose in human neuronal precursor cells (NPCs; Muotri et al. 2005 Muotri et al. , 2010 Coufal et al. 2009 Coufal et al. , 2011 and even more efficiently in mature nondividing neuronal cells (Macia et al. 2017) , suggesting that retrotransposition in the human brain might occur more frequently than expected.
L1-mediated retrotransposition can be mutagenic and thereby harmful for our genome. Actually, mutagenic L1 retrotransposition events have been implicated in more than 100 genetic diseases (Kazazian Jr et al. 1988; Kazazian Jr and Moran 2017; Beck et al. 2011; Kaer and Speek 2013; Hancks and Kazazian Jr 2016) . Moreover, somatic L1 retrotransposition may play a role in tumorigenesis (reviewed in Burns 2017) . For this reason, throughout evolution, cells have developed several mechanisms of defense to limit the expression and activity of these endogenous parasites.
Regulation of LINE-1 expression
A major control mechanism of L1 expression occurs through histone modifications and DNA methylation (Yoder et al. 1997; Bestor and Bourc'his 2004; Branco et al. 2011; Martens et al. 2005; Bulut-Karslioglu et al. 2014 ). L1 expression is also attenuated via premature polyadenylation at internal polyadenylation sites (Perepelitsa-Belancio and Deininger 2003; Han et al. 2004 ). Several acceptor and donor splicing sites were found within the L1 RNAs, suggesting a complex pattern of splicing that may limit the production of fulllength L1 RNA and thereby the retrotransposition (Belancio et al. 2006 (Belancio et al. , 2008 .
Furthermore, the cell developed a battery of transacting restriction factors that regulate the L1 life cycle using different mechanisms (reviewed in Goodier 2016; Pizarro and Cristofari 2016) . Many of these factors are involved in nucleic acid metabolism, and some are interferon-stimulated genes (ISGs) and have antiviral activities: this highlights their double function as regulators of both endogenous and exogenous parasites. Among these factors, three-prime repair exonuclease 1 (TREX1) and sterile alpha motif (SAM) domain and and histidine-aspartic (HD) domain 1 (SAMHD1) are worth mentioning. Loss-offunction mutations in these genes lead to the AicardiGoutières syndrome, a rare childhood inflammatory disorder (Crow and Manel 2015) . The TREX1 is an endogenous DNA exonuclease and its overexpression suppresses LINE-1 retrotransposition (Stetson et al. 2008) . Moreover, an increase of retroelement single-stranded DNA (ssDNA) was observed in the heart tissue of TREX1−/− mice, suggesting that this enzyme inhibits retrotransposition by digesting reverse-transcribed L1 cDNA (Stetson et al. 2008) . Recently, it has been shown that TREX1 may suppress L1 retrotransposition also through an exonuclease-independent pathway by triggering ORF1p depletion .
SAMHD1 is a dGTP-activated deoxynucleoside triphosphate triphosphohydrolase that inhibits L1 retrotransposition by reducing the level of ORF2p protein, thus affecting the L1 reverse transcriptase (Zhao et al. 2013) . Recently, Hu and colleagues provided evidences of a novel function of SAMHD1 in stimulating the formation of stress granules (SGs) and thus enhancing the sequestration of L1 RNP complexes in these granules (Hu et al. 2015) . This mechanism should impair nuclear import of L1 RNPs, thus affecting the retrotransposition process. SGs are cytoplasmic bodies induced in response to a variety of cellular stresses and accumulate untranslated mRNAs (Sheinberger and Shav-Tal 2017) . It was previously reported that L1 RNA, ORF1p and ORF2p localize in SGs, together with several L1 RNP-associated proteins (Doucet et al. 2010; Goodier et al. 2007 Goodier et al. , 2012 Goodier et al. , 2015 Gallois-Montbrun et al. 2007; Moldovan and Moran 2015) .
RNA-binding proteins as MOV10, ZAP and RNAse L inhibit L1 retrotransposition by affecting the intracellular level of the L1 RNA (Goodier et al. 2012 (Goodier et al. , 2015 Moldovan and Moran 2015; Zhang et al. 2014) . Of note, MOV10 and ZAP, but not RNase L, co-localize with L1 RNPs within SGs (Goodier et al. 2012 (Goodier et al. , 2015 Moldovan and Moran 2015; Zhang et al. 2014) .
The P-element-induced wimpy testes (PIWI)-interacting small RNA (piRNA) pathway is critical for the regulation of TEs in germline (reviewed in Zamudio and Bourc'his 2010; Russell et al. 2017) . In fact, PIWI proteins and piRNAs are an effective transposon defense mechanism occurring through degradation of transposon transcripts and induction of gene silencing by targeting de novo DNA methylation and transcriptional silencing of TEs (reviewed in Russell et al. 2017; Brennecke et al. 2008; Malone et al. 2009; Aravin et al. 2008; Kuramochi-Miyagawa et al. 2008) .
Many other factors restrict LINE-1 retrotransposition by different mechanisms, including methyl-cytosine modifying ten-eleven-translocation (Tet) proteins (Zhang et al. 2017) , the RNA interference pathway (Microprocessor complex, miR128), and these are described in details elsewhere (for reviews Heras et al. 2014; Goodier et al. 2016; Pizarro and Cristofari 2016) . Of note, different cellular deaminases belonging to the activation-induced deaminase (AID)/apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) and adenosine deaminases that act on RNA (ADAR) families were recently reported to restrict LINE-1 retrotransposition.
Cellular deaminases

AID/APOBEC family
Members of the AID /APOBEC family of proteins are responsible for the deamination of cytosine to uracil (C-to-U editing) within DNA (Beale et al. 2004; Bransteitter et al. 2003; Chaudhuri et al. 2003; Dickerson et al. 2003; Petersen-Mahrt and Neuberger 2003; Sohail et al. 2003) and RNA target molecules (Navaratnam et al. 1995; Sharma et al. 2015) .
In humans, the AID/APOBEC family includes 11 members: AID, APOBEC1, APOBEC2, seven APOBEC3 subfamily members (APOBEC3A, A P O B E C 3 B , A P O B E C 3 C , A P O B E C 3 D E , APOBEC3F, APOBEC3G and APOBEC3H; Salter et al. 2016 ) and APOBEC4 (Conticello 2008) . Catalytic activity could be demonstrated for all members of the AID/APOBEC family with the exception of APOBEC2 and APOBEC4 Marino et al. 2016) .
All the APOBEC proteins have at least one characteristic zinc-coordinating deaminase domain (ZDD) motif within an α-β-α super-secondary structural element that forms the core catalytic site of a cytidine deaminase (CDA) domain (Betts et al. 1994; Salter et al. 2016) . Among all APOBECs, APOBEC3B, APOBEC3DE, APOBEC3F and APOBEC3G contain two ZDD motifs ( Fig. 1a ; LaRue et al. 2009; Conticello et al. 2005) . Differences in length, composition and other structural features influence the enzyme's activity, oligomerization and substrate selectivity (Holden et al. 2008; Chen et al. 2008a; Furukawa et al. 2009; Salter et al. 2016; Siriwardena et al. 2016) . The APOBEC family probably evolved from AID and APOBEC2 (A2) genes trough gene duplication and divergence (LaRue et al. 2009; Conticello et al. 2005) . Their biological function was first characterized with the discovery of APOBEC1 (A1), that is responsible for the apolipoprotein B (apoB) mRNA C-to-U editing affecting lipid metabolism and transport (Teng et al. 1993; Navaratnam et al. 1995) , but it can also deaminate the 3' UTR of transcripts of other genes (Rosenberg et al. 2012; Rayon-Estrada et al. 2017) and acts also on DNA . Afterwards, the identification of a CDA domain motif within the AID primary amino acid sequence led to the prediction that AID might function as a cytosine deaminase (Muramatsu et al. 1999 ).
Yet, AID was characterized as a deoxycytidine deaminase causing multiple mutations required for immunoglobulin gene diversification and recombination (somatic hypermutation and class switch recombination; Petersen-Mahrt et al. 2002; Di Noia and Neuberger 2002; Li et al. 2004; Dickerson et al. 2003; Honjo et al. 2004; Papavasiliou and Schatz 2002) . Moreover, members of the APOBEC3 subfamily were found to contribute to restriction of viral infection (Chiu and Greene 2008; Harris and Dudley 2015) . APOBEC3G was the first enzyme described to restrict HIV-1 infection through extensive dC-to-dU hypermutation of proviral DNA during reverse transcription (Sheehy et al. 2002; Lecossier et al. 2003; Zhang et al. 2003; Mangeat et al. 2003; Harris et al. 2003) . APOBEC3 (A3) proteins show different expression profiles, cellular localization, editing context preference and restriction potency that regulate both the retrovirus' and retroelement's life cycles (Salter et al. 2016; Siriwardena et al. 2016) . Overall, the APOBEC proteins are part of the innate and adaptive immune response of the host cell anti-viral defense, and many members are implicated as a source of mutations that may drive carcinogenesis (reviewed in Salter et al. 2016; Swanton et al. 2015) . ADARs are enzymes that catalyze the hydrolytic deamination of adenosine to inosine within a double-stranded RNA (dsRNA) target (A-to-I editing). Editing by ADARs was originally characterized in Xenopus laevis as a dsRNA-unwinding activity (Bass and Weintraub 1987; Rebagliati and Melton 1987) . Only later, it was demonstrated that this activity was a consequence of the A-to-I editing in dsRNAs (Bass and Weintraub 1988) . Inosine is interpreted as guanosine by several cellular mechanisms, such as splicing, translation and reverse transcription (Bass et al. 1997 (Bass et al. , 2002 (Bass et al. , 2002 Goodman et al. 2012; Nishikura 2016) . As a consequence, A-to-I editing can potentially change the meaning of a specific codon, alter the splicing process, impair the microRNA processing and function, and affect several other aspects of RNA metabolism (Mannion et al. 2015; Nishikura 2016; Chen and Carmichael 2012; Wang et al. 2013; Ivanov et al. 2015; Hogg et al. 2011; Rueter et al. 1999; Chen et al. 2008b; Prasanth et al. 2005; Capshew et al. 2012; Vesely et al. 2012 Vesely et al. , 2014 . A-to-I editing occurs mostly in the non-coding regions (3' UTRs and introns) containing inversely oriented repeat elements, such as Alu and LINE-1 (Bazak et al. 2014; Ramaswami et al. 2012) .
Three ADAR enzymes have been identified in mammals, ADAR1, ADAR2 and ADAR3 (reviewed in Nishikura 2016; Mannion et al. 2015) . These enzymes have some common structural features, such as two or three dsRNA-binding domains (dsRBDs) at the N-terminus and a deaminase domain at the C-terminus (Goodman et al. 2012 ; Fig. 1b) . The ADAR catalytic domain is also present in the tRNA adenosine deaminases (ADATs) from which ADARs have been hypothesized to be evolved, and structurally related to those of APOBEC deaminases Keller 1999, 2001) . Only ADAR1 and ADAR2 are enzymatically active (Bass et al. 1997) and their dysregulation is associated with human diseases (reviewed in Song et al. 2016; Gallo et al. 2017) . In fact, mutations of the ADAR1 gene have been associated to AicardiGoutières syndrome (AGS) and dyschromatosis symmetrica hereditaria (DSH1), an autosomal dominant skin disorder (Rice et al. 2012; Miyamura et al. 2003) . Moreover, ADAR expression and activity are altered in a variety of cancers (i.e. hepatocellular carcinoma, glioblastoma and melanoma; reviewed in Rayon-Estrada et al. 2015; Fritzell et al. 2017 ).
ADAR1 is the most highly and widely expressed member of the ADAR family. There are two isoforms of ADAR1, the short form p110 that is constitutively expressed and mainly nuclear, and the long form p150 that is interferon-inducible and mainly localizes within the cytoplasm (Patterson and Samuel 1995; Strehblow et al. 2002) . ADAR1 is responsible for most of the promiscuous editing of dsRNA (Riedmann et al. 2008; Nishikura 2016; Mannion et al. 2015) .
Moreover, ADAR1 is a suppressor of IFN signaling (Hartner et al. 2009; Li et al. 2012) . It has been proposed that ADAR1 p150 editing marks endogenous dsRNAs as Bself^to distinguish them from exogenous, mostly viral, Bnon-self^dsRNAs in order to avoid the induction of an improper type I IFN response (Mannion et al. 2014; Liddicoat et al. 2015; Pestal et al. 2015; George et al. 2016; Heraud-Farlow et al. 2017) .
ADAR2 is nuclear and highly expressed in the central nervous system (CNS). Differently from ADAR1, ADAR2 is considered to be responsible for the majority of the site-specific editing events (Melcher et al. 1995; Nishikura 2016; Mannion et al. 2015) . Strikingly, very recently it has been shown that ADARs catalyze editing of the DNA strand in DNA/RNA hybrid substrates in vitro (Zheng et al. 2017) . If this activity is confirmed also in vivo, it will expand dramatically our knowledge about the function of these enzymes.
Finally, similar to components of the AID/APOBEC family, ADAR enzymes were previously reported to affect the life cycle of different viruses and retroelements (Samuel 2011; Tomaselli et al. 2015; Doria et al. 2009 Doria et al. , 2011 Orecchini et al. 2015 Orecchini et al. , 2017a , thus highlighting the importance of cellular deaminases as widespread regulators of endogenous and exogenous parasites.
Inhibition of LINE-1 and Alu retrotransposition mediated by cellular deaminases
Recently, by using a proteomic approach we have shown that ADAR1 associates with different RNAbinding proteins, a good fraction of which were previously identified as interacting factors of the L1 RNPs, suggesting a possible involvement of ADAR1 in the L1 life cycle (Orecchini et al. 2017a ). The knockdown of ADAR1 expression in HeLa cells was shown to increase the L1 retrotransposition efficiency in vitro (Orecchini et al. 2017a, b) . This result was further confirmed by over-expression experiments, wherein the increased level of the intracellular ADAR1 causes a correspondent reduction of L1 retrotransposition (Orecchini et al. 2017a) . These results provided the first evidence for a role of ADAR1 as a regulator of retroelements activity.
In an attempt to dissect the inhibitory mechanism mediated by ADAR1, it was first assayed whether the RNA editing activity of the enzyme was involved, by using an ADAR1 deletion mutant lacking the catalytic domain. The observation that its over-expression impairs L1 retrotransposition with an efficiency similar to that of the wt ADAR1 (Orecchini et al. 2017a) suggests that ADAR1 inhibits L1 retrotransposition by an editingindipendent mechanism. As a case point, no A-to-I editing events were identified in L1 RNA ectopically expressed in 293 T cells over-expressing ADAR1. Furthermore, co-immunoprecipitation experiments demonstrated the association between ADAR1 and the L1 RNP complex, in particular ORF1p and LINE-1 RNAs, as reported also for other RNA-binding proteins affecting L1 retrotransposition (Richardson et al. 2015; Goodier 2016; Pizarro and Cristofari 2016; Orecchini et al. 2017a) . Thus, it is plausible that ADAR1, by interacting with the L1 RNP complex might interfere with its function.
Differently from what has been observed for other regulators of L1 retrotransposition, knockdown of ADAR1 expression does not affect the intracellular accumulation of the ORF1p protein and/or L1 RNAs, thus suggesting an alternative mechanism of action (Orecchini et al. 2017a) .
Interestingly, ADAR1 co-localizes with ORF1p in SGs (Orecchini et al. unpublished data) . Although the reason for this subcellular co-localization of the L1 RNP is not yet clear, SAMHD1-mediated promotion of assembly of SGs is probably aimed at sequestering the L1 RNPs within the cytoplasm (Hu et al. 2015) . Thus, it can be envisioned that this inhibitory mechanism might be also exploited by ADAR1 and other L1 regulators.
Previous studies showed that only full-length ADAR1 p150 protein localizes within the SGs in response to particular stress conditions (Weissbach and Scadden 2012) . Thus, it is conceivable that this interferon-inducible isoform co-localizes with the L1 RNPs in SGs and thus might be responsible for the inhibition of L1 retrotransposition.
Finally, we have preliminary results showing that ADAR1 may repress Alu retrotransposition in vitro (Orecchini et al. unpublished) , and these results are in agreement with recently published data by Aktas and colleagues (Aktaş et al. 2017) , suggesting that ADAR1 p150 and DHX9 RNA helicase may protect cells from transposon insertions. Noteworthy, as mentioned above, the vast majority of known A-to-I editing events occur in the RNA duplex formed between adjacent inverted repetitive elements (in particular Alu; Bazak et al. 2014; Ramaswami et al. 2012) , thus it will be of great interest to test whether ADAR1 editing activity is critical for the suppression of Alu retrotransposition in vivo or, as for L1 suppression, editing is dispensable. Further experiments are required to determine the details of the mol e c u l a r m e c h a ni s m s c au s i n g r e pr e s s i o n o f retrotransposition mediated by ADAR1.
Several members of the AID/APOBEC family (AID, A1, A3A, A3B, A3C, A3DE, A3F and A3H) were shown to inhibit both LINE-1 and Alu retrotransposition (Pizarro and Cristofari 2016; Bogerd et al. 2006; Muckenfuss et al. 2006; Chen et al. 2006; Stenglein and Harris 2006; Kinomoto et al. 2007; Niewiadomska et al. 2007; Richardson et al. 2014; Koyama et al. 2013; Horn et al. 2014; Liang et al. 2016; Feng et al. 2017; Ikeda et al. 2011) . The majority of these experiments were carried out in cell cultures and the inhibition was found to be mainly mediated by editing-independent mechanisms (Pizarro and Cristofari 2016) .
Previous studies reported that wt A3A, but not deaminase-defective mutants, strongly inhibits L1 retrotransposition in cell culture (Chen et al. 2006; Muckenfuss et al. 2006; Kinomoto et al. 2007; Bogerd et al. 2006; Niewiadomska et al. 2007 ). However, these studies failed to detect deamination events in L1 sequences in cell lines over-expressing wt A3A. Recently, Richardson and colleagues demonstrated that A3A deaminates transiently exposed single-stranded DNA during the TPRT process in vitro (Richardson et al. 2014) , thus explaining how A3A might suppress L1 activity. A3A protein is highly expressed in peripheral blood mononuclear cells (PBMCs) and also detected in lung, adipose and placenta tissues (Chen et al. 2006; Muckenfuss et al. 2006; Kinomoto et al. 2007; Refsland et al. 2010 ), but not in hESCs (Wissing et al. 2011) . A3B is a nuclear protein expressed in hESCs and iPSCs (Muckenfuss et al. 2006; Kinomoto et al. 2007; Wissing et al. 2011) . The knockdown of A3B expression in HeLa cells and hESC cell lines resulted in a strong increase in L1 retrotransposition (Wissing et al. 2011) . The mechanism through which A3B inhibits L1 retrotransposition is still unknown, even though it does not seem to require deaminase activity. Interestingly, knocking down the expression of other APOBEC3 proteins (A3C, A3F, A3G and A3DE) did not result in a significant increase in L1 retrotransposition in hESCs.
Similarly to A3B, A3C was found to restrict L1 retrotransposition through an editing-independent mechanism (Horn et al. 2014) , as shown by experiments carried out with A3C mutants containing point mutations that abolish the catalytic activity, but maintain the anti-L1 activity. To suppress L1 mobilization, the oligomerization and the RNA binding capacity of the A3C are required. Furthermore, co-immunoprecipitation experiments demonstrated the interaction between ORF1p and A3C through RNA bridging molecules, and it was also shown that the physical association of A3C with the L1 RNP complex interferes with the L1 RT activity (Horn et al. 2014) . Notably, A3C co-localizes with L1 RNPs in SGs (Horn et al. 2014) .
Very recently, Liang and collaborators showed that A3DE, like A3B, potently inhibits L1 retrotransposition in 293 T cells (Liang et al. 2016) . A3DE is expressed in hESC, associates with ORF1p protein in an RNAdependent manner and this interaction causes a strong inhibition of the ORF2p RT activity (Liang et al. 2016) . The authors showed also a weak RNA-dependent interaction between A3B and ORF1p, but failed to observe any effect of this enzyme on ORF2p activity, thus suggesting a different inhibitory mechanism. Overall, A3B, A3C and A3DE proteins associate with the L1-RNP complex, but probably suppress L1 mobilization via different mechanisms. Finally, it has been demonstrated that some APOBEC3 proteins affect also the Alu retrotransposition. In particular A3A, A3B, A3DE and A3H were reported to be potent inhibitors of Alu retrotransposition, whereas A3C has a moderate effect in cell culture-based assays (Bogerd et al. 2006; Tan et al. 2009 ).
Of note, proteins not belonging to the APOBEC3 subfamily, such as AID and APOBEC1, were also found to suppress L1 retrotransposition with a deaminase-independent mechanism (MacDuff et al. 2009; Ikeda et al. 2011) . APOBEC1 from different mammal species was shown to inhibit L1 activity in vitro, with APOBEC1 from rabbit being the most potent. It was shown that APOBEC1 affects the accumulation of nascent L1 DNA (Ikeda et al. 2011) . Moreover, L1 RNA co-precipitated with the APOBEC1, thus suggesting an association of this enzyme with the L1 RNP complexes (Ikeda et al. 2011 ).
AID and catalytically inactive mutants were demonstrated to inhibit L1 retrotransposition in vitro (MacDuff et al. 2009 ). Furthermore, it was shown that neither the DNA binding activity nor a specific sub-cellular localization of the enzyme is critical for L1 restriction (MacDuff et al. 2009 ).
Even though cytidine deaminase activity does not seems to be required to suppress L1 activity by most AID/APOBEC proteins, previous experiments in cell lines showed that members of the APOBEC3 subfamily mediate restriction of LTR retrotransposons through a mechanism that relies on DNA editing (Esnault et al. 2005 (Esnault et al. , 2006 . This result was further confirmed by a computational screening of genomic sequences that found extensive DNA editing events of LTR retrotransposons (Anwar et al. 2013; Levanon 2015, 2016) . The different mechanism of restriction of LTR and non-LTR retrotransposons by AID/ APOBEC enzymes could be explained by how these parasites mobilize. The LTR elements are reversetranscribed like a retrovirus within the cytoplasm (Dewannieux et al. 2004) , whereas non-LTR retrotransposons mobilize by target-primed reverse transcription that occurs in the nucleus (Luan et al. 1993; Cost et al. 2002; Dewannieux et al. 2003) .
In contrast to the situation in mice, there is a striking coincidence between the expansion of the APOBEC3 gene cluster and the abrupt decline in retrotransposition activity in primates (Schumann 2007) , emphasizing the relevance of these enzymes as lines of defense of the human genome. Overall, even though the role of these cellular deaminases in restricting retrotransposons is now clear, many molecular details are still missing to d e t e r m i n e h o w d e a m i n a s e s a ff e c t L I N E -1 retrotransposition at the mechanistic level. Moreover, some of the results of these studies are controversial (such as the role of A3G and A3F in restricting L1 activity).
With regards to the AID/APOBEC family, most of the experiments were carried out by over-expressing the enzymes and their catalytic inactive forms in cell lines, an approach containing the intrinsic risk of false or notphysiological results. Moreover, even though the cellular localization of these proteins is well-characterized, only limited data is available on co-localization of APOBEC proteins with the L1 RNP complexes (only for A3C and A3DE), and in most cases biochemical studies to investigate the association between APOBEC proteins and L1 RNP complex are missing or limited. It is worth noting that, as described above, ADAR1 and members of the AID/APOBEC family share some common features as inhibitors of the L1 retrotransposition.
The expression of ADAR1 p150 and some APOBEC3 proteins are induced by type I interferon. Moreover, even though these enzymes are all catalytically active, they mostly suppress L1 retrotransposition via editing-independent mechanisms (A3A is the only known exception so far). This is an interesting observation, since APOBEC and ADAR enzymes regulate viral replication and/or infection using both deaminasedependent and -independent mechanisms, and APOBEC enzymes extensively mutate LTR retrotransposons (Salter et al. 2016; Samuel 2011; Levanon 2015, 2016) . Of note, ADAR1 and some APOBEC proteins associate with L1 RNAs (A1 and A3DE; Ikeda et al. 2011; Liang et al. 2016) . It would be of great interest to test whether this is true for all the family members. In fact, almost every member of the AID/APOBEC family interacts with RNA molecules even if they are not substrates for deamination, and this interaction may influence their function (Prohaska et al. 2014; Smith 2016 ).
The association with a variety of RNA molecules can cause multimerization of the APOBEC monomers giving rise to large RNP complexes (Gallois-Montbrun et al. 2007; Salter et al. 2016) . A3G can aggregate to form these high-molecular-weight complexes, and in this RNA-bound form A3G is enzymatically inactive (McDougall and Smith 2011) . The association with the RNA molecules seems to displace ssDNA from A3G and inhibits its deaminase activity (McDougall and Smith 2011) . Moreover, this large complex-containing A3G localizes in cytoplasmic bodies (Wichroski et al. 2006) . Notably, it was previously shown that RNA molecules may have an inhibitory effect on AID deamination of ssDNA (Bransteitter et al. 2003) . Recently, an RNA-mediated mechanism of targeting AID to DNA (S region) during class switch recombination has been unveiled (Zheng et al. 2015) .
RNA molecules (viral genomic RNA or cellular RNAs) are critical for the incorporation of APOBEC3G into the viral particles (Khan et al. 2007 ). Thus it can be envisioned that binding of L1 RNAs by some members of the AID/APOBEC family may inhibit their catalytic activity, in turn stimulating their editingindependent functions that cause L1 restriction. Finally, ADAR enzymes can bind and deaminate DNA strands in DNA/RNA hybrids in vitro. Thus, we may hypothesize that ADAR1 through the binding of DNA/RNA hybrids generated during the reverse transcriptase step of the TPRT process, may impair mobilization by a mechanism that could be either editingdependent or -independent. It would be important to test w h e t h e r A D A R 1 a f f e c t s t h e RT s t e p o f retrotransposition, as observed for some APOBEC proteins.
Open questions
There are still several open questions that must to be answered in order to understand in detail how cellular deaminases affect retrotransposon activity: 
Conclusions
TEs represent roughly 50% of the human genome. LINE-1 is the only autonomous active family of TEs in humans. Even though the majority of the LINE-1 elements in the human genome are inactive due to 5′ truncation, mutations and internal rearrangements, there are still about 100 copies that retain the ability to retrotranspose. Retrotransposition can impact the human genome, leading to several disorders; thus, several lines of defense have been evolved in the host cells to restrict the activity of these endogenous parasites. Recent investigations have provided evidence of a role of cellular deaminases, such as AID/APOBEC and ADAR enzymes, as host factors that limit retrotransposon mobilization. These enzymes, except A3A, inhibit L1 retrotransposition by editing-independent mechanisms. Due to the important implications of such findings in both physiology and pathology, future studies are required to shed light on the mechanisms through which these enzymes inhibit retrotransposition and on the conditions that can perturb them.
